Moderator:

Daniel R. Goldstein, MD, University of Michigan, Ann Arbor, MI, USA Editor-in-Chief, Journal of Heart and Lung Transplantation

Welcome and Introductory Comments
Daniel R. Goldstein, MD, University of Michigan, Ann Arbor, MI, USA

Introduction of Presentation 1
Andrew Gelman, PhD, Washington University School of Medicine, St Louis, MO, USA
Deputy Editor, Pre-clinical/Experimental Studies

Presentation 1: MicroRNA-206 Antagomir Enriched Extracellular Vesicles Attenuate Lung Ischemia-Reperfusion Injury Via CXCL1 Regulation in Alveolar Epithelial Cells
Ashish K. Sharma, MBBS, PhD, University of Florida Gainesville, FL, USA

Live Q & A

Introduction of Presentation 2
Joseph Rossano, MD, University of Pennsylvania, Philadelphia, PA, USA
Deputy Editor, Pediatric Cardiac Transplantation

Presentation 2: Transplantation for Congenital Heart Disease is Associated With an Increased Risk of Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder in Children
Simon Bomken, MBBS (Hons), PhD, MRCPCH, BMedSci (Hons), Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle Upon Tyne, United Kingdom

Live Q & A

Introduction of Presentation 3
Michelle Kittleson, MD, PhD, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
Deputy Editor, Cardiac Transplantation

Presentation 3: Increased Early Acute Cellular Rejection Events in Hepatitis C-Positive Heart Transplantation
Claudia G. Gidea, MD, New York University Medical Center, New York, NY, USA

Live Q & A

Closing Remarks
Daniel R. Goldstein, MD, University of Michigan, Ann Arbor, MI, USA

ISHLT Announcements
Greg Schultz, CEO, ISHLT, Addison, TX, USA

Continuing Education Information

No Continuing Education Credit will offered for this session.